Literature DB >> 24280870

Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies.

Che-Ming J Hu1, Ronnie H Fang, Brian T Luk, Liangfang Zhang.   

Abstract

Long-circulating polymeric nanotherapeutics have garnered increasing interest in research and in the clinic owing to their ability to improve the solubility and pharmacokinetics of therapeutic cargoes. Modulation of carrier properties promises more effective drug localization at the disease sites and can lead to enhanced drug safety and efficacy. In the present review, we highlight the current development of polymeric nanotherapeutics in the clinic. In light of the importance of stealth properties in therapeutic nanoparticles, we also review the advances in stealth functionalization strategies and examine the performance of different stealth polymers in the literature. In addition, we discuss the recent development of biologically inspired "self" nanoparticles, which present a differing stealth concept from conventional approaches.

Year:  2013        PMID: 24280870     DOI: 10.1039/c3nr05444f

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  51 in total

1.  Self-assembled Targeting of Cancer Cells by Iron(III)-doped, Silica Nanoparticles.

Authors:  K K Pohaku Mitchell; S Sandoval; M J Cortes-Mateos; J G Alfaro; A C Kummel; W C Trogler
Journal:  J Mater Chem B       Date:  2014-12-07       Impact factor: 6.331

2.  Erythrocyte-Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization.

Authors:  Diana Dehaini; Xiaoli Wei; Ronnie H Fang; Sarah Masson; Pavimol Angsantikul; Brian T Luk; Yue Zhang; Man Ying; Yao Jiang; Ashley V Kroll; Weiwei Gao; Liangfang Zhang
Journal:  Adv Mater       Date:  2017-02-15       Impact factor: 30.849

3.  Nanotherapeutics for autoimmunity becomes mainstream.

Authors:  Nick Giannoukakis; Wilson S Meng
Journal:  Clin Immunol       Date:  2015-07-11       Impact factor: 3.969

4.  Novel Core-Interlayer-Shell DOX/ZnPc Co-loaded MSNs@ pH-Sensitive CaP@PEGylated Liposome for Enhanced Synergetic Chemo-Photodynamic Therapy.

Authors:  Jinyuan Ma; Hongjie Wu; Yang Li; Zehua Liu; Guihua Liu; Yuxin Guo; Zhenqing Hou; Qingliang Zhao; Dengyue Chen; Xuan Zhu
Journal:  Pharm Res       Date:  2018-02-08       Impact factor: 4.200

Review 5.  The use of CD47-modified biomaterials to mitigate the immune response.

Authors:  Jillian E Tengood; Robert J Levy; Stanley J Stachelek
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

6.  Biomimetic Targeting of Nanoparticles to Immune Cell Subsets via Cognate Antigen Interactions.

Authors:  Brian T Luk; Yao Jiang; Jonathan A Copp; Che-Ming J Hu; Nishta Krishnan; Weiwei Gao; Shulin Li; Ronnie H Fang; Liangfang Zhang
Journal:  Mol Pharm       Date:  2018-03-16       Impact factor: 4.939

7.  Evolution and Clinical Translation of Drug Delivery Nanomaterials.

Authors:  Shabir Hassan; Gyan Prakash; Aycabal Ozturk; Saghi Saghazadeh; Mohammad Farhan Sohail; Jungmok Seo; Mehmet Dockmeci; Yu Shrike Zhang; Ali Khademhosseini
Journal:  Nano Today       Date:  2017-08-02       Impact factor: 20.722

Review 8.  Nanoparticle-hydrogel superstructures for biomedical applications.

Authors:  Yao Jiang; Nishta Krishnan; Jiyoung Heo; Ronnie H Fang; Liangfang Zhang
Journal:  J Control Release       Date:  2020-05-26       Impact factor: 9.776

9.  Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles.

Authors:  Brian T Luk; Che-Ming Jack Hu; Ronnie H Fang; Diana Dehaini; Cody Carpenter; Weiwei Gao; Liangfang Zhang
Journal:  Nanoscale       Date:  2014-01-27       Impact factor: 7.790

10.  Cyclodextrin polymers as nanocarriers for sorafenib.

Authors:  Valentina Giglio; Maurizio Viale; Vittorio Bertone; Irena Maric; Rita Vaccarone; Graziella Vecchio
Journal:  Invest New Drugs       Date:  2017-11-08       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.